Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study. (Q51371877)
Jump to navigation
Jump to search
scientific article published in November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study. |
scientific article published in November 2011 |
Statements
1 reference
Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study. (English)
1 reference
K Kaku
1 reference
T Itayasu
1 reference
S Hiroi
1 reference
M Hirayama
1 reference
Y Seino
1 reference
1 November 2011
1 reference
13
1 reference
11
1 reference
1028-1035
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference